🔴 Milestone Pharmaceuticals is trading 5.7% down today as healthcare ETF falls 2.19%

Milestone Pharmaceuticals is trading 5.7% down at $1.13 as healthcare stocks broadly face pressure during the September 8, 2026 session.

• Healthcare ETF is down 2.19%, providing the clearest explanation for the decline.
• No new negative company-specific announcement was identified.
• Milestone’s September 3 release announced China’s NMPA approval for etripamil and a $2.0 million payment, which was positive rather than a clear catalyst for today’s drop.